KRRO

Korro Bio, Inc. - Common Stock (KRRO)

About Korro Bio, Inc. - Common Stock (KRRO)

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Details

Daily high

$20.11

Daily low

$16.72

Price at open

$16.99

52 Week High

$98.00

52 Week Low

$11.13

Market cap

153.4M

Dividend yield

0.00%

Volume

152,194

Avg. volume

118,528

P/E ratio

-1.74

Korro Bio, Inc. - Common Stock News